Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bopei Cui

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Viruses|April 30, 2021
Cross-Antigenicity between EV71 Sub-Genotypes: Implications for Vaccine EfficacyPei Liu, Yadi Yuan, Bopei Cui, et al.
Human Vaccines & Immunotherapeutics|November 10, 2021
Evaluation of the cross-neutralization activities elicited by Coxsackievirus A10 vaccine strainsYaqian Huo, Jinghuan Yang, Pei Liu, et al.
Viruses|November 11, 2022
A Short 5'triphosphate RNA nCoV-L Induces a Broad-Spectrum Antiviral Response by Activating RIG-IZiyang Song, Qian Wang, Lianlian Bian, et al.
Molecular Therapy. Oncology|February 3, 2026
An attenuated coxsackievirus B5 mutant carrying VP1-N157K retains oncolytic potency against non-small cell lung cancerLifang Song, Bopei Cui, Qiushuang Gao, et al.
Human Vaccines & Immunotherapeutics|August 5, 2020
A uniform quantitative enzyme-linked immunosorbent assay for Coxsackievirus A16 antigen in vaccineBopei Cui, Fang Cai, Fan Gao, et al.
Vaccine|March 1, 2022
Establishment of the first Chinese national standard for protein subunit SARS-CoV-2 vaccineFan Gao, Chaoqiang An, Lianlian Bian, et al.
Emerging Microbes & Infections|July 19, 2021
Boosting with heterologous vaccines effectively improves protective immune responses of the inactivated SARS-CoV-2 vaccineJialu Zhang, Qian He, Chaoqiang An, et al.
Frontiers in Immunology|March 3, 2023
Establishment of national standard for anti-SARS-Cov-2 neutralizing antibody in China: The first National Standard calibration traceability to the WHO International StandardLidong Guan, Qunying Mao, Dejiang Tan, et al.
Signal Transduction and Targeted Therapy|September 24, 2023
Non-small cell lung cancers (NSCLCs) oncolysis using coxsackievirus B5 and synergistic DNA-damage response inhibitorsBopei Cui, Lifang Song, Qian Wang, et al.
Frontiers in Immunology|September 5, 2022
Heterologous immunization with adenovirus vectored and inactivated vaccines effectively protects against SARS-CoV-2 variants in mice and macaquesQian He, Qunying Mao, Jialu Zhang, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Viruses|April 30, 2021
Cross-Antigenicity between EV71 Sub-Genotypes: Implications for Vaccine EfficacyPei Liu, Yadi Yuan, Bopei Cui, et al.
Human Vaccines & Immunotherapeutics|November 10, 2021
Evaluation of the cross-neutralization activities elicited by Coxsackievirus A10 vaccine strainsYaqian Huo, Jinghuan Yang, Pei Liu, et al.
Viruses|November 11, 2022
A Short 5'triphosphate RNA nCoV-L Induces a Broad-Spectrum Antiviral Response by Activating RIG-IZiyang Song, Qian Wang, Lianlian Bian, et al.
Molecular Therapy. Oncology|February 3, 2026
An attenuated coxsackievirus B5 mutant carrying VP1-N157K retains oncolytic potency against non-small cell lung cancerLifang Song, Bopei Cui, Qiushuang Gao, et al.
Human Vaccines & Immunotherapeutics|August 5, 2020
A uniform quantitative enzyme-linked immunosorbent assay for Coxsackievirus A16 antigen in vaccineBopei Cui, Fang Cai, Fan Gao, et al.
Vaccine|March 1, 2022
Establishment of the first Chinese national standard for protein subunit SARS-CoV-2 vaccineFan Gao, Chaoqiang An, Lianlian Bian, et al.
Emerging Microbes & Infections|July 19, 2021
Boosting with heterologous vaccines effectively improves protective immune responses of the inactivated SARS-CoV-2 vaccineJialu Zhang, Qian He, Chaoqiang An, et al.
Frontiers in Immunology|March 3, 2023
Establishment of national standard for anti-SARS-Cov-2 neutralizing antibody in China: The first National Standard calibration traceability to the WHO International StandardLidong Guan, Qunying Mao, Dejiang Tan, et al.
Signal Transduction and Targeted Therapy|September 24, 2023
Non-small cell lung cancers (NSCLCs) oncolysis using coxsackievirus B5 and synergistic DNA-damage response inhibitorsBopei Cui, Lifang Song, Qian Wang, et al.
Frontiers in Immunology|September 5, 2022
Heterologous immunization with adenovirus vectored and inactivated vaccines effectively protects against SARS-CoV-2 variants in mice and macaquesQian He, Qunying Mao, Jialu Zhang, et al.
Pageof 2